University of Wisconsion solution versus celsior solution in clinical pancreas transplantation

U. Boggi, S. Signori, F. Vistoli, M. Del Chiaro, A. Pietrabissa, C. Croce, M. Barsotti, T. Vanadia Bartolo, G. Amorese, E. Capocasale, R. Della Valle, M. P. Mazzoni, F. Mosca

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Introduction. This study compared the safety and efficacy of University of Wisconsin solution (UW) and Celsior solution (C) in pancreas transplantation (PTx). Methods. A retrospective review of 154 PTx performed over a 61-month period included 77 grafts preserved with UW and 77 with C. The two groups were comparable for both donor and recipient characteristics. Results. After a mean cold ischemia time of 624 minutes (range 360 to 945 minutes) for UW versus 672 minutes (range 415 to 1005 minutes) for C (P = NS), no primary endocrine nonfunction occurred. Delayed endocrine function was diagnosed in two grafts in the UW group (2.6%) versus none in the C group (P = NS). After a minimum follow-up of 4 months (mean 26.5 ± 15.2 months), 22 recipients (UW = 11 vs C = 11; P = NS) required relaparotomy. Overall, 18 pancreata were lost due to either patient death with functioning graft (UW = 4 vs C = 1; P = NS) or graft loss due to other reasons (UW = 8 vs C = 5; P = NS). Actuarial 1- and 5-year patient survival rates were 93.5% and 86.8% for UW compared with 98.7% and 98.7% for C (P = .04). Actuarial graft survival rates at the same times were 88.3% and 75.0% for UW compared with 90.4% and 90.4% for C (P = NS). Conclusions. Within the range of cold ischemia times reported in this study, UW and C show similar safety and efficacy profiles for PTx.

Original languageEnglish
Pages (from-to)1262-1264
Number of pages3
JournalTransplantation Proceedings
Volume37
Issue number2
DOIs
Publication statusPublished - Mar 2005

Fingerprint

Pancreas Transplantation
Transplants
Cold Ischemia
Celsior
Survival Rate
Safety
Graft Survival
Pancreas
Tissue Donors

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

University of Wisconsion solution versus celsior solution in clinical pancreas transplantation. / Boggi, U.; Signori, S.; Vistoli, F.; Del Chiaro, M.; Pietrabissa, A.; Croce, C.; Barsotti, M.; Vanadia Bartolo, T.; Amorese, G.; Capocasale, E.; Della Valle, R.; Mazzoni, M. P.; Mosca, F.

In: Transplantation Proceedings, Vol. 37, No. 2, 03.2005, p. 1262-1264.

Research output: Contribution to journalArticle

Boggi, U, Signori, S, Vistoli, F, Del Chiaro, M, Pietrabissa, A, Croce, C, Barsotti, M, Vanadia Bartolo, T, Amorese, G, Capocasale, E, Della Valle, R, Mazzoni, MP & Mosca, F 2005, 'University of Wisconsion solution versus celsior solution in clinical pancreas transplantation', Transplantation Proceedings, vol. 37, no. 2, pp. 1262-1264. https://doi.org/10.1016/j.transproceed.2005.01.040
Boggi, U. ; Signori, S. ; Vistoli, F. ; Del Chiaro, M. ; Pietrabissa, A. ; Croce, C. ; Barsotti, M. ; Vanadia Bartolo, T. ; Amorese, G. ; Capocasale, E. ; Della Valle, R. ; Mazzoni, M. P. ; Mosca, F. / University of Wisconsion solution versus celsior solution in clinical pancreas transplantation. In: Transplantation Proceedings. 2005 ; Vol. 37, No. 2. pp. 1262-1264.
@article{da8fa92b731049008bbce437a00b2c1b,
title = "University of Wisconsion solution versus celsior solution in clinical pancreas transplantation",
abstract = "Introduction. This study compared the safety and efficacy of University of Wisconsin solution (UW) and Celsior solution (C) in pancreas transplantation (PTx). Methods. A retrospective review of 154 PTx performed over a 61-month period included 77 grafts preserved with UW and 77 with C. The two groups were comparable for both donor and recipient characteristics. Results. After a mean cold ischemia time of 624 minutes (range 360 to 945 minutes) for UW versus 672 minutes (range 415 to 1005 minutes) for C (P = NS), no primary endocrine nonfunction occurred. Delayed endocrine function was diagnosed in two grafts in the UW group (2.6{\%}) versus none in the C group (P = NS). After a minimum follow-up of 4 months (mean 26.5 ± 15.2 months), 22 recipients (UW = 11 vs C = 11; P = NS) required relaparotomy. Overall, 18 pancreata were lost due to either patient death with functioning graft (UW = 4 vs C = 1; P = NS) or graft loss due to other reasons (UW = 8 vs C = 5; P = NS). Actuarial 1- and 5-year patient survival rates were 93.5{\%} and 86.8{\%} for UW compared with 98.7{\%} and 98.7{\%} for C (P = .04). Actuarial graft survival rates at the same times were 88.3{\%} and 75.0{\%} for UW compared with 90.4{\%} and 90.4{\%} for C (P = NS). Conclusions. Within the range of cold ischemia times reported in this study, UW and C show similar safety and efficacy profiles for PTx.",
author = "U. Boggi and S. Signori and F. Vistoli and {Del Chiaro}, M. and A. Pietrabissa and C. Croce and M. Barsotti and {Vanadia Bartolo}, T. and G. Amorese and E. Capocasale and {Della Valle}, R. and Mazzoni, {M. P.} and F. Mosca",
year = "2005",
month = "3",
doi = "10.1016/j.transproceed.2005.01.040",
language = "English",
volume = "37",
pages = "1262--1264",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "2",

}

TY - JOUR

T1 - University of Wisconsion solution versus celsior solution in clinical pancreas transplantation

AU - Boggi, U.

AU - Signori, S.

AU - Vistoli, F.

AU - Del Chiaro, M.

AU - Pietrabissa, A.

AU - Croce, C.

AU - Barsotti, M.

AU - Vanadia Bartolo, T.

AU - Amorese, G.

AU - Capocasale, E.

AU - Della Valle, R.

AU - Mazzoni, M. P.

AU - Mosca, F.

PY - 2005/3

Y1 - 2005/3

N2 - Introduction. This study compared the safety and efficacy of University of Wisconsin solution (UW) and Celsior solution (C) in pancreas transplantation (PTx). Methods. A retrospective review of 154 PTx performed over a 61-month period included 77 grafts preserved with UW and 77 with C. The two groups were comparable for both donor and recipient characteristics. Results. After a mean cold ischemia time of 624 minutes (range 360 to 945 minutes) for UW versus 672 minutes (range 415 to 1005 minutes) for C (P = NS), no primary endocrine nonfunction occurred. Delayed endocrine function was diagnosed in two grafts in the UW group (2.6%) versus none in the C group (P = NS). After a minimum follow-up of 4 months (mean 26.5 ± 15.2 months), 22 recipients (UW = 11 vs C = 11; P = NS) required relaparotomy. Overall, 18 pancreata were lost due to either patient death with functioning graft (UW = 4 vs C = 1; P = NS) or graft loss due to other reasons (UW = 8 vs C = 5; P = NS). Actuarial 1- and 5-year patient survival rates were 93.5% and 86.8% for UW compared with 98.7% and 98.7% for C (P = .04). Actuarial graft survival rates at the same times were 88.3% and 75.0% for UW compared with 90.4% and 90.4% for C (P = NS). Conclusions. Within the range of cold ischemia times reported in this study, UW and C show similar safety and efficacy profiles for PTx.

AB - Introduction. This study compared the safety and efficacy of University of Wisconsin solution (UW) and Celsior solution (C) in pancreas transplantation (PTx). Methods. A retrospective review of 154 PTx performed over a 61-month period included 77 grafts preserved with UW and 77 with C. The two groups were comparable for both donor and recipient characteristics. Results. After a mean cold ischemia time of 624 minutes (range 360 to 945 minutes) for UW versus 672 minutes (range 415 to 1005 minutes) for C (P = NS), no primary endocrine nonfunction occurred. Delayed endocrine function was diagnosed in two grafts in the UW group (2.6%) versus none in the C group (P = NS). After a minimum follow-up of 4 months (mean 26.5 ± 15.2 months), 22 recipients (UW = 11 vs C = 11; P = NS) required relaparotomy. Overall, 18 pancreata were lost due to either patient death with functioning graft (UW = 4 vs C = 1; P = NS) or graft loss due to other reasons (UW = 8 vs C = 5; P = NS). Actuarial 1- and 5-year patient survival rates were 93.5% and 86.8% for UW compared with 98.7% and 98.7% for C (P = .04). Actuarial graft survival rates at the same times were 88.3% and 75.0% for UW compared with 90.4% and 90.4% for C (P = NS). Conclusions. Within the range of cold ischemia times reported in this study, UW and C show similar safety and efficacy profiles for PTx.

UR - http://www.scopus.com/inward/record.url?scp=17844365869&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17844365869&partnerID=8YFLogxK

U2 - 10.1016/j.transproceed.2005.01.040

DO - 10.1016/j.transproceed.2005.01.040

M3 - Article

C2 - 15848689

AN - SCOPUS:17844365869

VL - 37

SP - 1262

EP - 1264

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - 2

ER -